Company Filing History:
Years Active: 2024
Title: Innovations by Kellisa Beth Hansen
Introduction
Kellisa Beth Hansen is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic formulations. With a total of 2 patents, her work focuses on innovative solutions for treating respiratory conditions.
Latest Patents
Hansen's latest patents include groundbreaking work on dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies. These formulations are designed for pulmonary delivery and aim to provide effective treatment methods for asthma. The technology relates to the use of specific antibodies that target TSLP, which plays a crucial role in the immune response.
Career Highlights
Kellisa Beth Hansen has established herself as a key figure in her field through her innovative research and development efforts. Her work at Medimmune Limited has allowed her to explore new therapeutic avenues and contribute to advancements in asthma treatment.
Collaborations
Hansen has collaborated with esteemed colleagues, including Catherine Eugenie Chaillan Huntington and Susan Hoe. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Kellisa Beth Hansen's contributions to the field of biomedical research exemplify the impact of innovation in healthcare. Her patents and collaborative efforts continue to pave the way for advancements in asthma treatment and beyond.